FOAM FORMULATION OF IMMUNE RESPONSE MODIFIER, METHOD FOR PREPARING BASED DRUG PREPARATION (VERSION) AND THERAPEUTIC KIT CONTAINING SAID FORMULATION Russian patent published in 2013 - IPC A61K31/4745 A61K31/4375 A61K47/12 A61P17/12 A61P17/16 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to a foam formulation of an immune response modifier. The foam formulation of the immune response modifier, which contains: imiquimod; isostearic acid; a propellant; a mixture of preserving agents; sorbitan monostearate; a viscosifying agent taken in a specific ratio. A kit containing a drug preparation and an aerosol bottle. The use of the foam formulation for treating senile keratosis, basal cell skin cancer, anogenital warts, photodamaged skin, or for improving skin characteristics, cervical dysplasia, viral diseases, particularly herpes, skin metastases, skin damages caused by bites, self-healing epithelioma, for inducing interferon biosynthesis (versions).

EFFECT: above-described foam formulation of the immune response modifier is stable.

24 cl, 8 tbl, 1 ex